3 years ago
DFTX
AnalystsFrancois BriseboisFrancois Brisebois's Stock Forecasts
AnalystsFrancois Brisebois
Analyst Ranking
Bottom 5%
#4935 out of 5185 analysts
Average Return
-4.36%
Win Rate
38%37 out of 98
Risk vs Reward
Poor
Good
Francois Brisebois's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Definium Therapeutics IncDFTX | +206.01% | $3.16 | $9.67 | 2023-04-14 - 2024-04-12 | Buy |
Praxis Precision Medicines IncPRAX | +187.18% | $69.99 | $201.00 | 2024-10-31 - 2025-10-30 | Buy |
Tarsus Pharmaceuticals IncTARS | +143.94% | $15.59 | $38.03 | 2023-05-08 - 2024-05-07 | Buy |
Mediwound LtdMDWD | +120.20% | $8.75 | $19.27 | 2023-08-17 - 2024-08-16 | Buy |
Ovid Therapeutics IncOVID | +109.18% | $0.74 | $1.55 | 2025-01-29 - 2026-01-28 | Buy |
Francois Brisebois Analyst Color
Get additional color on Francois Brisebois's coverage of popular stocks
Francois Brisebois's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Aquestive Therapeutics IncAQST | 3 | Buy | $8.00 | +171.19% | Maintains | 5 months ago |
Savara IncSVRA | 6 | Buy | $6.00 | +11.11% | Maintains | 6 months ago |
Sensei Biotherapeutics IncSNSE | 2 | Buy | $80.00 | +742.11% | Maintains | 10 months ago |
Abeona Therapeutics IncABEO | 1 | Buy | $16.00 | +214.34% | Initiates Coverage On | a year ago |
Ovid Therapeutics IncOVID | 1 | Buy | $4.00 | N/A | Upgrades | a year ago |
Tarsus Pharmaceuticals IncTARS | 7 | Buy | $72.00 | N/A | Maintains | a year ago |
Harmony Biosciences Holdings IncHRMY | 6 | Buy | $61.00 | N/A | Maintains | a year ago |
Definium Therapeutics IncDFTX | 4 | Buy | $20.00 | N/A | Reiterates | a year ago |
Entrada Therapeutics IncTRDA | 2 | Buy | $28.00 | N/A | Maintains | a year ago |
Avadel Pharmaceuticals PLCAVDL | 8 | Buy | $30.00 | N/A | Maintains | a year ago |
Praxis Precision Medicines IncPRAX | 4 | Buy | $163.00 | N/A | Maintains | a year ago |
Dyne Therapeutics IncDYN | 5 | Buy | $55.00 | N/A | Reiterates | a year ago |
Kala Bio IncKALA | 2 | Buy | $15.00 | N/A | Reiterates | a year ago |
Diamedica Therapeutics IncDMAC | 5 | Buy | $6.00 | N/A | Reiterates | a year ago |
Achieve Life Sciences IncACHV | 6 | Buy | $11.00 | N/A | Reiterates | a year ago |
Centessa Pharmaceuticals PLCCNTA | 2 | Buy | $14.00 | N/A | Reiterates | a year ago |
Adverum Biotechnologies IncADVM | 1 | Buy | $25.00 | N/A | Initiates Coverage On | 2 years ago |
Simulations Plus IncSLP | 5 | Buy | $65.00 | N/A | Maintains | 2 years ago |
Aldeyra Therapeutics IncALDX | 2 | Buy | $10.00 | N/A | Reiterates | 2 years ago |
Durect CorpDRRX | 2 | Buy | $5.00 | N/A | Reiterates | 2 years ago |
Cybin IncHELP | 2 | Buy | $152.00 | N/A | Reiterates | 2 years ago |
Mediwound LtdMDWD | 3 | Buy | $36.00 | N/A | Maintains | 2 years ago |
Icad IncICAD | 3 | Buy | $4.00 | N/A | Maintains | 3 years ago |
Processa Pharmaceuticals IncPCSA | 3 | Buy | $1,500.00 | N/A | Maintains | 3 years ago |
Bionano Genomics IncBNGO | 2 | Buy | $5,400.00 | N/A | Maintains | 3 years ago |
9 Meters Biopharma IncNMTRQ | 1 | Buy | $100.00 | N/A | Maintains | 3 years ago |
Sera Prognostics IncSERA | 2 | Buy | $11.00 | N/A | Maintains | 3 years ago |
Dermtech IncDMTKQ | 2 | Buy | $23.00 | N/A | Maintains | 3 years ago |
Mdxhealth SaMDXH | 1 | Buy | $18.00 | N/A | Assumes | 4 years ago |
Otonomy IncOTIC | 1 | Buy | $6.00 | N/A | Maintains | 4 years ago |
Compass Pathways PLCCMPS | 1 | Buy | $50.00 | N/A | Initiates Coverage On | 4 years ago |
Strongbridge Biopharma PLCSBBP | 2 | Hold | $3.25 | N/A | Downgrades | 5 years ago |
Flexion Therapeutics IncFLXN1 | 1 | Buy | $19.00 | N/A | Initiates Coverage On | 6 years ago |
Galmed Pharmaceuticals LtdGLMD | 1 | Buy | $3,240.00 | N/A | Initiates Coverage On | 6 years ago |
Intercept Pharmaceuticals IncICPT | 3 | Strong Buy | $130.00 | N/A | Upgrades | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.